Maggot Therapy and Compassionate Use of Insects

Sterile maggot therapy for wound debridement raises interesting welfare questions about compassionate use of insects for animal and human benefit.

Key Facts

Sterile Lucilia sericata (greenbottle fly) larvae are approved medical devices for wound debridement in over 40 countries
Maggots clear necrotic tissue from chronic wounds without damaging healthy tissue more effectively than surgical debridement in some cases
The larvae used are raised under controlled conditions specifically for medical use
Whether maggots experience pain during the wound-cleaning process is unknown but they have functional nociceptors
The net welfare balance involves potential insect discomfort weighed against healing benefits for patients

Welfare Considerations

Maggot therapy presents a genuinely complex welfare calculation: insect welfare of uncertain significance weighed against therapeutic benefit for vertebrate patients. The precautionary approach suggests minimizing duration of larval exposure and developing alternatives. However, the therapeutic value in wound care that resists other treatment makes this one of the more defensible uses of invertebrates in medical contexts.

What You Can Do

Support research into insect sentience to better inform welfare calculations in medical insect use
Advocate for minimum necessary duration and quantity principles in maggot therapy protocols
Engage with the emerging literature on invertebrate welfare and its implications for medicine